Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mione

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
The International Journal of Biological Markers|July 1, 1992
Cost/effectiveness ratio of carcinoembryonic antigen--importance of adequacy of routine requests of tumor markersM Gion, A Rampazzo, R Mione, et al.
Anticancer Research|July 1, 1996
Dynamic use of tumor markers, rationale-clinical applications and pitfallsM Gion, R Mione, P Barioli, et al.
Clinical Chemistry|May 1, 1999
Comparison of the diagnostic accuracy of CA27.29 and CA15.3 in primary breast cancerM Gion, R Mione, A E Leon, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|October 1, 1994
Tissue polypeptide antigen and tissue polypeptide specific antigen in primary breast cancer. Evaluation in serum and tumour tissueM Gion, R Mione, P Barioli, et al.
Cancer|March 1, 1986
Carcinoembryonic antigen, ferritin, and tissue polypeptide antigen in serum and tissue. Relationship with the receptor content in breast carcinomaM Gion, R Mione, R Dittadi, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 29, 1998
How CA 125 is used in the routine follow-up of ovarian cancer: a survey of 29 Italian hospitalsM Gion, P Barioli, A Ponti, et al.
Cancer|February 1, 1989
A mucinous-like carcinoma-associated antigen (MCA) in the tissue and blood of patients with primary breast cancerE Bombardieri, M Gion, R Mione, et al.
The International Journal of Biological Markers|March 18, 1999
How tumor markers are used in the routine follow-up of breast and colorectal cancer. A survey of 29 Italian hospitalsM Gion, P Barioli, A Ponti, et al.
International Journal of Oncology|May 17, 2011
Ca549 immunoassay in breast-tissue - comparison with ca15.3 and mcaM Gion, M Plebani, R Mione, et al.
British Journal of Cancer|April 1, 1994
Serum CA549 in primary breast cancer: comparison with CA15.3 and MCAM Gion, M Plebani, R Mione, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
The International Journal of Biological Markers|July 1, 1992
Cost/effectiveness ratio of carcinoembryonic antigen--importance of adequacy of routine requests of tumor markersM Gion, A Rampazzo, R Mione, et al.
Anticancer Research|July 1, 1996
Dynamic use of tumor markers, rationale-clinical applications and pitfallsM Gion, R Mione, P Barioli, et al.
Clinical Chemistry|May 1, 1999
Comparison of the diagnostic accuracy of CA27.29 and CA15.3 in primary breast cancerM Gion, R Mione, A E Leon, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|October 1, 1994
Tissue polypeptide antigen and tissue polypeptide specific antigen in primary breast cancer. Evaluation in serum and tumour tissueM Gion, R Mione, P Barioli, et al.
Cancer|March 1, 1986
Carcinoembryonic antigen, ferritin, and tissue polypeptide antigen in serum and tissue. Relationship with the receptor content in breast carcinomaM Gion, R Mione, R Dittadi, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 29, 1998
How CA 125 is used in the routine follow-up of ovarian cancer: a survey of 29 Italian hospitalsM Gion, P Barioli, A Ponti, et al.
Cancer|February 1, 1989
A mucinous-like carcinoma-associated antigen (MCA) in the tissue and blood of patients with primary breast cancerE Bombardieri, M Gion, R Mione, et al.
The International Journal of Biological Markers|March 18, 1999
How tumor markers are used in the routine follow-up of breast and colorectal cancer. A survey of 29 Italian hospitalsM Gion, P Barioli, A Ponti, et al.
International Journal of Oncology|May 17, 2011
Ca549 immunoassay in breast-tissue - comparison with ca15.3 and mcaM Gion, M Plebani, R Mione, et al.
British Journal of Cancer|April 1, 1994
Serum CA549 in primary breast cancer: comparison with CA15.3 and MCAM Gion, M Plebani, R Mione, et al.
Pageof 5